Bevacizumab (Avastin) and RAD001(Everolimus)in the Treatment of Advanced Clear Cell Renal Carcinoma
Clinical trial NCT00323739 · COMPLETED
Trial details
- NCT number
- NCT00323739
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-05-01
- Primary completion
- 2008-11-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.